GlobeNewswire
-
Nyxoah Obtains Default Decision Against Inspire Medical Systems in Unified Patent Court Case
18/11/2026 -
Olema Oncology Presents Preclinical Data on Selective KAT6A Degraders in ER+/HER2- Breast Cancer Models at EORTC-NCI-AACR Symposium
18/11/2026 -
Adaptive Biotechnologies Highlights clonoSEQ’s Central Role in Advancing MRD-Guided Care Across Hematology at ASH 2026
18/11/2026 -
Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Increased Dose of 15 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study
18/11/2026 -
UREVO Announces Black Friday Sale 2026 with Its Biggest Discounts of the Year
18/11/2026 -
Medline Inc. announces pricing of secondary offering of Class A common stock
18/11/2026 -
Novartis showcases hematology momentum and continued breast cancer leadership at ASH and SABCS
18/11/2026 -
Novo Nordisk Foundation commits US$60 million to strengthen CARB-X efforts against antimicrobial resistance
18/11/2026 -
Zealand Pharma announces initiation of the Phase 2 ZYNERGY trial of petrelintide co-administered with enicepatide in people with obesity or overweight
18/11/2026 -
CytomX Therapeutics Announces Milestone Achievement in Strategic Collaboration with Regeneron in the Field of Conditionally Activated Bispecifics
17/11/2026 -
Gain Therapeutics Presents Clinical Data from Phase 1b Study of Rexaceract and Preclinical Data from Novel GCase Modulator GT-04686
17/11/2026 -
InspireMD to Host KOL Webinar on Carotid Artery Disease Management and the Clinical Benefits of InspireMD’s CGuard Prime Carotid Stent Platform
17/11/2026 -
Biogen’s Diranersen Demonstrates Increasing Clinical Benefit at Two Years in Early Alzheimer’s Disease
17/11/2026 -
BioSyent Declares Fourth Quarter 2026 Dividend
17/11/2026 -
BioSyent Releases Financial Results for Q3 and YTD 2026
17/11/2026 -
Portsmouth Square, Inc. Reports First Quarter Fiscal 2027 Results; Pedestrian Bridge Removal Complete and Hotel Reopened After City-Mandated Closure
17/11/2026 -
Erasca Enters into Clinical Collaboration with Bristol Myers Squibb to Evaluate ERAS-0015 in Clinical Study with Navlimetostat
18/11/2026 -
Non-Surgical Hair Restoration in NYC: Park Avenue Practice Opens Dedicated GLP-1 Hair Loss Assessments for January, With Procedure Decided Only After Blood Work
17/11/2026 -
COP31 : l’EAACI appelle à intégrer les allergies et la santé respiratoire dans les politiques de lutte contre le changement climatique
17/11/2026
Pages